Advance your next cancer research breakthrough.

Preclinical Oncology

In 2019 we welcomed the preclinical pharmacology oncology provider, MI Bioresearch, into the Labcorp family. Now you can access hundreds of cell line assays and tumor models, as well as thousands of potential oncology patients for clinical trials or explore an extensive library of oncology diagnostics.

Cell Lines Tumor Models CAR T In Vitro Model & Tech Spotlights Posters Fast Track Discovery Program

Advance your preclinical oncology compounds with a comprehensive suite of preclinical oncology studies, including in vitro and in vivo pharmacology efficacy models, in vivo imaging technologies as well as focal radiation capabilities.

When your research has the potential to save lives, you deserve a partner with the oncology pharmacology knowledge, breadth of tools and experience to move life-changing drug candidates through non-GLP, preclinical development and oncology clinical trials quickly and efficiently.

We've helped hundreds of companies discover their next life-improving compound.

Cell Lines & Tumor Models

Browse hundreds of cell line growth curves in our complete cell line list or read our spotlights on tumor models.

Immunotherapy & Adoptive Cell Therapy Support

We offer over 30 different syngeneic tumor models, from both solid and disseminated origins, to provide you with many choices to further your immuno-oncology research. We are continually improving and expanding adoptive cell therapy capabilities:

Flow Cytometry, Imaging and Radiation

For over a decade, we have offered an industry-leading array of in vivo imaging modalities for optimum pharmacologic interrogation when needed. These include:

PRECLINICAL ONCOLOGY RENOVATION

Fully invested in your fight against cancer from the very beginning

The fight against cancer starts in the lab. That’s why we’ve invested in a renovation that doubled the size of our preclinical oncology facility in Ann Arbor, Michigan. Here you can discover enhanced capabilities and greater capacity to speed up your preclinical oncology programs.

Let's start a conversation

Preclinical Oncology